[HTML][HTML] Caffeic acid ethanolamide induces antifibrosis, anti-inflammatory, and antioxidant effects protects against bleomycin-induced pulmonary fibrosis
CW Huang, SY Lee, CX Du, ST Wu, YH Kuo… - Biomedicine & …, 2024 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease; its
cause is unknown, and it leads to notable health problems. Currently, only two drugs are …
cause is unknown, and it leads to notable health problems. Currently, only two drugs are …
Caffeic acid ethanolamide induces antifibrosis, anti-inflammatory, and antioxidant effects protects against bleomycin-induced pulmonary fibrosis.
CW Huang, SY Lee, CX Du, ST Wu… - Biomedicine & …, 2024 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease; its
cause is unknown, and it leads to notable health problems. Currently, only two drugs are …
cause is unknown, and it leads to notable health problems. Currently, only two drugs are …
Caffeic acid ethanolamide induces antifibrosis, anti-inflammatory, and antioxidant effects protects against bleomycin-induced pulmonary fibrosis
CW Huang, SY Lee, CX Du, ST Wu… - Biomedicine & … - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease; its
cause is unknown, and it leads to notable health problems. Currently, only two drugs are …
cause is unknown, and it leads to notable health problems. Currently, only two drugs are …